Exagen Inc. Common Stock (XGN) is a publicly traded Healthcare sector company. As of May 21, 2026, XGN trades at $3.83 with a market cap of $84.32M and a P/E ratio of -4.24. XGN moved +2.95% today. Year to date, XGN is -35.63%; over the trailing twelve months it is -35.74%. Its 52-week range spans $2.38 to $12.23. Analyst consensus is strong buy with an average price target of $8.67. Rallies surfaces XGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own XGN include Bluecrest Capital. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Exagen Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $3.83 |
| Market Cap | $84.32M |
| P/E Ratio | -4.24 |
| EPS | $-0.89 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.23 |
| 52-Week Low | $2.38 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $68.38M |
| Net Income | $-20.17M |
| Gross Margin | 58.32% |
7 analysts cover XGN: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.67.